News & Resources
Read our latest insights and explore our resources, including company updates, articles, white papers, case studies, webinars and more.
-
Clinical trial access in the US: Where are today’s trials missing?
We use the latest clinical trial data to map out active site locations and understand how healthcare deserts are affecting clinical trial access in the United States, and how this can be addressed. According to the latest data from CISCRP, the physical location/proximity of a research study center is one […]
-
Quality in Motion: Meet Our Mobile Clinicians: Hope Horton
Meet Hope Horton, a dedicated Certified Mobile Research Nurse (CMRN) at PCM Trials. CMRNs support clinical trial participation beyond traditional settings by traveling to trial participants anytime, anywhere to perform mobile visits. Through a series of questions, Hope offers an intimate look into the impactful and rewarding world of CMRNs, highlighting their […]
-
EmVenio Research Commits to SCRS Global Impact Partner Program
June 6th, 2024 – The Society for Clinical Research Sites (SCRS) proudly announces the addition of EmVenio Research to its Global Impact Partner (GIP) Program. EmVenio, a PCM Trials company, is part of the largest independent decentralized clinical trial (DCT) site network and a premier provider of local clinical trial […]
-
EmVenio Research’s May 2024 Community Engagement Highlights
Our collaboration with local organizations creates opportunity to address critical health issues and topics through the lens of clinical research, promoting wellness, and bringing value to the communities we serve. The well-being of our communities remains at the forefront. Together, we strive towards creating a healthier and more interconnected society, […]
-
PCM Trials Achieves Important Data Privacy Milestones
PCM Trials is excited to announce that we have successfully self-certified for the EU-U.S. Data Privacy Framework (DPF), the UK Extension to the EU-U.S. DPF, and the Swiss-U.S. DPF. These frameworks provide an approved mechanism for the transfer of personal data from the European Economic Area, the United Kingdom and […]
-
Decentralized Clinical Trials for older adults: Mobile research trends and recommendations
Data shows the industry is turning towards decentralization to study the effects of drugs in older populations, but how can Decentralized Clinical Trials (DCTs) be implemented in a suitable, age-appropriate way? In the United States, the number of adults aged 65 and over is expected to grow sharply over the […]
-
Walgreens and Boehringer Ingelheim Are Partnering to Improve Diversity in Clinical Trials
Joint collaborations bring Boehringer Ingelheim’s Phase III clinical trial to communities through Walgreens pharmacy clinical trial centers and EmVenio’s mobile research units, aimed at improving access to trials DEERFIELD, Ill. and RIDGEFIELD, Conn., May 2, 2024 — Walgreens and Boehringer Ingelheim today announced a strategic collaboration aimed at optimizing recruitment and […]
-
Advancements in Decentralized Clinical Trials: The Impact of AI on Mobile Visits
In this expert panel discussion, speakers Weiss, Kelly, and Lipset reflect on the FDA’s recent AI guidance and ponder its influence on patient-centric DCTs. They examine lessons from DCT adoption, stressing the importance of global harmonization and the ethical use of AI. A deep dive into challenges and prospects, this […]
-
Quality in Motion: Meet Our Mobile Clinicians: Nikki Degreeff
Meet Nikki Degreeff, a Clinical Project Manager who began her journey with PCM Trials as a Certified Mobile Research Nurse (CMRN). CMRNs support clinical trial participation beyond a physical research site by traveling to trial participants anytime, anywhere to perform mobile visits. Through a series of questions, Nikki offers an intimate […]
-
February 2024 Community Engagement
Over the past few months, EmVenio has led a series of impactful events in Alabama, Illinois, and Florida, to boost community well-being. These local connections raise awareness about the importance of clinical research and offer local residents the opportunity to prioritize their health through complimentary health screenings administered by our […]
-
PCM Trials closes second strategic acquisition of 2024
The Denver Business Journal details our recent acquisition of EmVenio Research, and our second acquisition of 2024. The acquisition grants PCM Trials access to new, mobile community site networks in the United States and United Kingdom. The acquisition of EmVenio Research, along with PCM Trials of Clinical Trial Service in […]
-
The importance of pediatric participation: Can mobile visits attract and keep more children in clinical trials?
Research shows there is a concerning lack of children in studies for conditions that affect them. As sponsors face regulatory pressure to include more pediatric patients in trials, could decentralized studies supported by mobile nurse visits help them enroll more patients from this underrepresented group? Empirically valid information documenting the […]
